• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP TOXOPLASMA M (TOXO M) ASSAY; TOXO M IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP TOXOPLASMA M (TOXO M) ASSAY; TOXO M IMMUNOASSAY Back to Search Results
Model Number N/A
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 08/24/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The cause for the discordant negative advia centaur xp toxoplasma m result is unknown.Siemens is investigating.The instructions for use (ifu) under the interpretation of results section states the following: "the detection of toxoplasma igm in a given specimen, as determined by assays from different manufacturers, can vary due to differences in assay methods and reagent specificity." the instructions for use (ifu) under the limitation section states the following: "patient specimens collected very early during the acute phase of infection may contain toxoplasma igm levels below the cutoff of the advia centaur toxo m assay.Additionally, diagnosis of a recent infection should not be made based on a single sampling because igm antibodies to t.Gondii may persist in serum many months after infection.The presence of igm antibodies to t.Gondii is not diagnostic for recent infection.Mdr 1219913-2017-00256 was filed for the same complaint from a new sample draw on a different day for the same patient.
 
Event or Problem Description
A false negative advia centaur xp toxoplasma m (toxo m) result was obtained by the customer on a patient known to be pregnant.The negative toxo m result considered discordant compared to a positive reference laboratory test method result.The patient sample was sent to the reference laboratory for further testing, and the toxo m result was positive.A corrective report was issued.The same patient was redrawn at a later date ((b)(6) 2017), and the advia centaur xp toxo m result was negative (refer to mdr 1219913-2017-00256).There are no reports that treatment was altered or prescribed or adverse health consequences due to the discordant advia centaur xp toxo m result.
 
Additional Manufacturer Narrative
Siemens filed the initial mdr 1219913-2017-00255 on (b)(6) 2017 for a false negative advia centaur xp toxoplasma m (toxo m) patient result.On (b)(6) 2018 additional information: siemens has requested further information for investigation, however none has been provided.The cause false negative advia centaur xp toxoplasma m (toxo m) patient result is unknown, and it appears to be sample/patient specific.Siemens is not aware of other false negative advia centaur xp toxoplasma m (toxo m) patient results with reagent lot 080278.The instrument is performing within specifications.No further investigation is required.Mdr 1219913-2017-00256 was filed for the same patient for a redrawn sample, and mdr 1219913-2017-00256 supplemental report 1 for additional information.
 
Additional Manufacturer Narrative
Siemens filed the initial mdr 1219913-2017-00255 on 12/11/2017 for a false negative advia centaur xp toxoplasma m (toxo m) result, and mdr 1219913-2017-00255 supplemental 1 on 01/22/2018 for additional information.02/02/2018 - correction: siemens was informed by the customer that the reference in relevant tests/lab data to a new sample collected on (b)(6) 2017 was in error.There was no new sample or patient result.The instrument is performing within specifications.No further investigation is required.Mdr 1219913-2017-00256 was filed for a false negative advia centaur xp toxoplasma m (toxo m) result on a redrawn sample.Mdr 1219913-2017-00256 supplemental report 1 was filed for additional information and mdr 1219913-2017-00256 supplemental report 2 was filed for the same relevant tests/lab data correction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP TOXOPLASMA M (TOXO M) ASSAY
Common Device Name
TOXO M IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
MDR Report Key7106826
Report Number1219913-2017-00255
Device Sequence Number1874214
Product Code LGD
UDI-Device Identifier00630414208442
UDI-Public00630414208442
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K010755
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional,u
Initial Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/27/2017
Device Model NumberN/A
Device Catalogue Number10310320
Device Lot Number080278
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 11/24/2017
Supplement Date Received by Manufacturer01/17/2018
02/02/2018
Initial Report FDA Received Date12/11/2017
Supplement Report FDA Received Date01/22/2018
02/09/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age39 YR
-
-